Adrianne Vaughn
Allergy · San Antonio, TXNPI 1649263740
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 26.1% of the total.
Across 101 payments — averaging $66.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Sanofi$479
- Regeneron Healthcare Solutions, Inc.$377
- Novartis$343
- Shire North American Group Inc$247
- plus $2K from 15 others
What the payments were for
- Food & beverage$6,713100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 25 | $1,749 |
| GSK | 32 | $1,579 |
| Sanofi | 5 | $479 |
| Regeneron Healthcare Solutions, Inc. | 4 | $377 |
| Novartis | 6 | $343 |
| Shire North American Group Inc | 2 | $247 |
| Genentech USA, Inc. | 6 | $237 |
| Grifols USA, LLC | 2 | $204 |
| Alk-abello, Inc | 3 | $162 |
| Genentech, Inc. | 2 | $155 |
| Sunovion Pharmaceuticals Inc. | 2 | $141 |
| Blueprint Medicines Corporation | 2 | $132 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Incyte Corporation | 1 | $125 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $112 |
| Kaleo, Inc. | 1 | $100 |
| Pfizer | 1 | $99 |
| Amgen | 1 | $97 |
| CSL Behring | 1 | $91 |
| ADMA Biomanufacturing LLC | 1 | $91 |
| Sanofi-aventis U.S. LLC | 2 | $67 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,713 in reported general payments places this provider in the 60th percentile of 69 allergy providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 24 | $86,530 |
| Breo ElliptaFluticasone/Vilanterol | 36 | $20,776 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $17,574 |
| Advair HfaFluticasone Propion/Salmeterol | 13 | $5,349 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 41 | $5,335 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $3,145 |
| Epinephrine | 14 | $3,129 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 25 | $2,360 |
| Montelukast Sodium | 146 | $1,865 |
| Azelastine Hcl | 35 | $1,196 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $858 |
| Cefdinir | 43 | $838 |
| Mometasone Furoate | 12 | $640 |
| Famotidine | 14 | $375 |
| Azithromycin | 20 | $222 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Trelegy Ellipta | $1,579 | $38,34965 claims |
| AstraZenecaSymbicort | $1,749 | $3,14514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 69 allergy providers in Texas.
Other allergy in San Antonio
- Patricia DingerSan Antonio$15K
- David HrncirSan Antonio$7K
- Roberto RodriguezSan Antonio$7K
- Dennis DilleySan Antonio$6K
- John FreilerSan Antonio$6K
- Eliseo VillalobosSan Antonio$4K
- Bruce MartinSan Antonio$356
- Gary GrossDallas$602K
- Rene LeonSouthlake$48K
- Christina HuddlestonDallas$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.